These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 27734836)

  • 1. Onco-GPCR signaling and dysregulated expression of microRNAs in human cancer.
    Nohata N; Goto Y; Gutkind JS
    J Hum Genet; 2017 Jan; 62(1):87-96. PubMed ID: 27734836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.
    Arang N; Gutkind JS
    FEBS Lett; 2020 Dec; 594(24):4201-4232. PubMed ID: 33270228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of G-protein-coupled receptor signaling in cancer biology and gene transcription.
    Spiegelberg BD; Hamm HE
    Curr Opin Genet Dev; 2007 Feb; 17(1):40-4. PubMed ID: 17188489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Illuminating the Onco-GPCRome: Novel G protein-coupled receptor-driven oncocrine networks and targets for cancer immunotherapy.
    Wu V; Yeerna H; Nohata N; Chiou J; Harismendy O; Raimondi F; Inoue A; Russell RB; Tamayo P; Gutkind JS
    J Biol Chem; 2019 Jul; 294(29):11062-11086. PubMed ID: 31171722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.
    Li S; Huang S; Peng SB
    Int J Oncol; 2005 Nov; 27(5):1329-39. PubMed ID: 16211229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptors as promising cancer targets.
    Liu Y; An S; Ward R; Yang Y; Guo XX; Li W; Xu TR
    Cancer Lett; 2016 Jul; 376(2):226-39. PubMed ID: 27000991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of autophagy with microRNAs and their potential therapeutic implications in human cancers.
    Jing Z; Han W; Sui X; Xie J; Pan H
    Cancer Lett; 2015 Jan; 356(2 Pt B):332-8. PubMed ID: 25304373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.
    O'Hayre M; Vázquez-Prado J; Kufareva I; Stawiski EW; Handel TM; Seshagiri S; Gutkind JS
    Nat Rev Cancer; 2013 Jun; 13(6):412-24. PubMed ID: 23640210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Introduction: G Protein-coupled Receptors and RGS Proteins.
    Stewart A; Fisher RA
    Prog Mol Biol Transl Sci; 2015; 133():1-11. PubMed ID: 26123299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrantly expressed microRNAs in bladder cancer and renal cell carcinoma.
    Kurozumi A; Goto Y; Okato A; Ichikawa T; Seki N
    J Hum Genet; 2017 Jan; 62(1):49-56. PubMed ID: 27357429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
    Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
    J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecules targeting heterotrimeric G proteins.
    Ayoub MA
    Eur J Pharmacol; 2018 May; 826():169-178. PubMed ID: 29522725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs dysregulated in breast cancer preferentially target key oncogenic pathways.
    Lim WK; Micklem G
    Mol Biosyst; 2011 Sep; 7(9):2571-6. PubMed ID: 21766137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptome Profiling of Dysregulated GPCRs Reveals Overlapping Patterns across Psychiatric Disorders and Age-Disease Interactions.
    Monfared RV; Alhassen W; Truong TM; Gonzales MAM; Vachirakorntong V; Chen S; Baldi P; Civelli O; Alachkar A
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of microRNA-143 in different signal pathways in cancer: New insights into cancer therapy.
    Karimi L; Mansoori B; Shanebandi D; Mohammadi A; Aghapour M; Baradaran B
    Biomed Pharmacother; 2017 Jul; 91():121-131. PubMed ID: 28448866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissection of aberrant GPCR signaling in tumorigenesis--a systems biology approach.
    Wu J; Xie N; Zhao X; Nice EC; Huang C
    Cancer Genomics Proteomics; 2012 Jan; 9(1):37-50. PubMed ID: 22210047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G Protein-Coupled Receptor (GPCR) Expression in Native Cells: "Novel" endoGPCRs as Physiologic Regulators and Therapeutic Targets.
    Insel PA; Wilderman A; Zambon AC; Snead AN; Murray F; Aroonsakool N; McDonald DS; Zhou S; McCann T; Zhang L; Sriram K; Chinn AM; Michkov AV; Lynch RM; Overland AC; Corriden R
    Mol Pharmacol; 2015 Jul; 88(1):181-7. PubMed ID: 25737495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. microRNA and NF-kappa B.
    Yuan Y; Tong L; Wu S
    Adv Exp Med Biol; 2015; 887():157-70. PubMed ID: 26662991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPCR oligomers in pharmacology and signaling.
    González-Maeso J
    Mol Brain; 2011 May; 4(1):20. PubMed ID: 21619615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic profiling of microRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice.
    Zhao Y; Xie P; Fan H
    Environ Sci Technol; 2012 Jan; 46(1):34-41. PubMed ID: 21882851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.